Filing Flows › Inogen (INGN) › Q2 2026 › vs Q1 2026
Inogen (INGN) Q2 2026 vs Q1 2026 (quarter over quarter)
Inogen's revenue rose $10.0M (+12%) from $85.1M in Q1 2026 to $95.1M in Q2 2026.
Inogen, Q2 2026: revenue $95.1M (+3% year over year), operating margin -5.4%, net loss $3.9M, operating cash flow $2.9M. The chart draws each line against Q1 2026, the increases inside each band.
Margins
| Q2 2026 | Q1 2026 | Change | |
|---|---|---|---|
| Free cash flow margin | 2.4% | -8.1% | +10.5 pts |
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $95.1M | $85.1M | $10.0M | +12% |
| Other income, net | $1.1M | $838K | $254K | +30% |
| Income tax benefit | $154K | $174K | −$20K | -11% |
| Net loss | $3.9M | $8.3M | −$4.5M | -54% |
| Costs & expenses | $100M | $94.4M | $5.7M | +6% |
| Operating costs | $100M | $94.4M | $5.7M | +6% |
| Cost of revenue | $51.8M | $47.2M | $4.6M | +10% |
| Research & development | $5.9M | $5.1M | $774K | +15% |
| Sales & marketing | $24.8M | $24.6M | $221K | +0.9% |
| General & admin | $17.7M | $17.5M | $174K | +1% |
| Operating cash sources | $6.8M | $1.6M | $5.2M | +315% |
| Depreciation & amortization | $4.7M | $4.9M | −$207K | -4% |
| Share-based compensation | $1.8M | $1.9M | −$179K | -9% |
| Working capital & other | $328K | −$5.2M | $5.5M | — |
| Net loss absorbed | $3.9M | $8.3M | −$4.5M | -54% |
| Operating cash flow | $2.9M | −$6.7M | $9.6M | — |
| Free cash flow (OCF − capex) | $2.2M | −$6.9M | $9.1M | — |
| Capital expenditures | $711K | $210K | $501K | +239% |
Questions
How much did Inogen's revenue grow quarter over quarter in Q2 2026?
Inogen's revenue rose $10.0M (+12%) from $85.1M in Q1 2026 to $95.1M in Q2 2026.